BNR - CIK 0001792267
Burning Rock Biotech Ltd (BNR) reported net income of -$7.92M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$7.92M | +83.3% |
| FY 2024 | -$47.49M | +48.4% |
| FY 2023 | -$92.07M | +34.6% |
| FY 2022 | -$140.81M | -12.6% |
| FY 2021 | -$125.02M | -100.3% |
| FY 2020 | -$62.41M | - |
Burning Rock Biotech Ltd (BNR) reported net income of -$7.92M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Burning Rock Biotech Ltd's net income grew from -$62.41M to -$7.92M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.